As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: August 6, 2014
by Fredrick Kunkle for The Washington Post:
People with moderate-to-severe vitamin D deficiencies are significantly more likely to develop Alzheimer’s disease or other forms of dementia than those who have an adequate supply of the vitamin in their body, a new study has found.
Researchers, led by David J. Llewellyn at the University of Exeter Medical School, found that adults who suffered from a moderate deficiency of vitamin D had a 53 percent higher risk of some form of dementia, while the risk increased 125 percent in those with severe deficiencies. People moderately deficient in vitamin D were 69 percent more likely to develop Alzheimer’s-caused dementia, while those severely deficient raised the risk to 122 percent.
The team discovered what appear to be clear threshold levels for brain health using standard medical measurements of concentration in the blood. The risk of dementia appears to rise for people with vitamin D blood levels below 25 nanomoles per liter, while vitamin D levels above 50 nanomoles appear to be good levels for brain health.
The researchers acknowledged the possibility of reverse causation — that is, that having dementia might alter a person’s behavior or diet in such a way as to contribute to vitamin D deficiency — but suggested that the makeup of the study made that unlikely.
Llewellyn said that although the international team of researchers expected to find a link between vitamin D deficiency and dementia, the strong correlation between the two was surprising. He said further study was necessary to determine whether consuming oily fish or vitamin D supplements might prevent Alzheimer’s disease.
“We thought it was important for bone health. But there’s this recent revelation that it might be playing an important role throughout the body,” Llewellyn said. He said more recent research suggests that vitamin D may act as a buffer regulating calcium levels in brain cells.
Alzheimer’s disease is the leading form of dementia, affecting more than 5 million people in the United States. That number is expected to reach 16 million by 2050 as the population ages.
Vitamin D, which helps the body use calcium, is created when skin is exposed to sunshine. Milk is often fortified with the vitamin, and it is also found in fatty fish and other foods.
Researchers in the Exeter study noted that laboratory experiments have shown that vitamin D may play a role in ridding cells of beta-amyloid plaques, an abnormality that distinguishes Alzheimer’s.
“It seems to be that vitamin D was actually helping to break down and take away those protein abnormalities,” Llewellyn said Wednesday in an interview.
Knowing that previous studies have also linked vitamin D deficiency to heightened risk of cognitive decline in older people, the multinational team of researchers studied vitamin D blood levels in 1,658 people age 65 and older who were able to walk, free of dementia, and without a history of cardiovascular disease or stroke. Medical personnel tracked the subjects over six years, using brain scans, cognitive tests, medical records and other diagnostic tools, to see how many developed Alzheimer’s disease or other forms of dementia.
The study, funded in part by the Alzheimer’s Association, appeared Wednesday in Neurology, the medical journal of the American Academy of Neurology.
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.